Status:
UNKNOWN
The Copmparison of Accuracy of PtcCO2 and in PetCO2 in COPD Patients
Lead Sponsor:
The First Affiliated Hospital of Guangzhou Medical University
Conditions:
COPD
Eligibility:
All Genders
20-100 years
Brief Summary
The pathophysiological characteristics of COPD is irreversible airflow restriction which may influence the gas exchange and cause the abnormal PaO2 and PaCO2. Assessment of the partial arterial pressu...
Eligibility Criteria
Inclusion
- COPD patients
Exclusion
- hemodynamics is unstable;
- any other lung disease despite COPD；
- other diseases influencing experiments: Cognitive impairment disease、 mouth and nose trauma.
Key Trial Info
Start Date :
August 10 2019
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04051931
Start Date
August 10 2019
End Date
June 1 2020
Last Update
October 23 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510000